Immune
JAIDS Journal of Acquired Immune Deficiency Syndromes
aDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, CA;
bDivision of Pharmacotherapy and Expe...
Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer
Differences in the tumor immune microenvironment may result in differences in prognosis and response to treatment in cancer patients. We hypothesiz...
The prostate cancer androgen receptor cistrome in African American men associates with upregulation of lipid metabolism and immune response
African American (AA) men are more likely to be diagnosed with and die from prostate cancer (PCa) than European American (EA) men. Despite the cent...
Differences in Immune Cell Mitochondrial Function in Black and White Patients with Heart Failure with Preserved Ejection Fraction
Background:
Heart failure with preserved ejection fraction (HFpEF) affects patients of all races and ethnicities. However, Black/Afr...
Disparities in Representation of Women, Older Adults and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials
Purpose:
We aim to describe reporting and representation of minority patient populations in immune checkpoint inhibitor (ICI) clinic...
Deleterious AHNAK2 Mutation as a Novel Biomarker for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
doi: 10.3389/fonc.2022.798401.
eCollection 2022.
Affiliations
Expand
...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
